Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Clinical Infectious Diseases, Volume 77, No. 3, Year 2023

In this international, multicenter open-label study (ACTG A5379) of HepB-CpG vaccine in people with human immunodeficiency virus (HIV) without prior hepatitis B virus (HBV) vaccination, all 68 participants achieved HBV seroprotective titers after the 3-dose series in the primary analysis. No unexpected safety issues were observed.

Statistics
Citations: 13
Authors: 13
Affiliations: 12
Identifiers
Doi: 10.1093/cid/ciad201
ISSN: 10584838
e-ISSN: 15376591
Research Areas
Infectious Diseases

Disclaimer

All information and calculations provided are based on our current indexed publications and may change as more data is collected.

African Research Nexus

The African Research Nexus is a visionary initiative that seeks to increase the visibility of African Researchers and Institutions. We are a dynamic hub designed to transform the African research landscape and amplify the voices of our continent’s brightest minds.

Useful Links

ABOUT US
PROFILES
Authors Directory
AI Digest
CONTACT US

Subscribe Now
Don’t miss our future updates!

Follow Us